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Five  asymptomatic  human  immunodeficiency  vi- 
rus  (H1V)-seropositive  male  homosexuals  were  im- 
munized  with  the  recall  antigens  tetanus  toxoid (TT) 
and  the  three  types of poliovirus  present  in  diphthe- 
ria, tetanus, and polio vaccine. Four weeks after 
immunization,  the  in  vivo  response to booster  im- 
munization,  the  in  vitro  pokeweed  mitogen (PWM)- 
induced IgG secretion, and the in vitro T cell-de- 
pendent  and T cell-independent  antigen-induced  an- 
tibody response were assayed. Increase in serum 
antibody titer to TT and poliovirus was low and 
normal,  respectively. In all  five  subjects  studied,  a 
high  rate  of  spontaneous IgG production,  including 
antibodies  directed  toward HIV was  observed.  Ad- 
dition of PWM to the  cultures induced  suppression 
of the  spontaneous IgG secretion. Only one  donor 
showed a slightly increased IgG production after 
stimulation with PWM. Peripheral blood mononu- 
clear cells of four  of the  five  HIV-seropositive  indi- 
viduals did not produce TT. or poliovirus-specific 
antibodies when stimulated  with  the  respective T 
cell-dependent antigens. However, stimulation of 
these peripheral  blood  mononuclear cells with TT 
coupled to agarose  beads,  which  was  shown to be T 
cell-independent,  resulted  in  the  generation of IgG 
anti-TT  antibody-forming cells. 
Human immunodeficiency virus (HIV)' is a recently 
discovered member of the Lentivirinae  subfamily of the 
Retroviridae family, and is cytotropic and cytopathic for 
T lymphocytes with the  cluster designation (CD) 4 
(helper/inducer) phenotype (1-3). HIV has been impli- 
cated as the  cause of acquired immunodeficiency syn- 
drome (AIDS), of AIDS-related complex (ARC), and of a 
degeneration of the  central nervous  system (1, 2.  4-7). 
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After an asymptomatic period of some weeks to  several 
years,  infection  with HIV may result  in  disease  symptoms 
caused by immunosuppression.  The  immune  system of 
patients  with AIDS or ARC is characterized by a decrease 
in CD4/CD8 (T  helper/T  suppressor) cell ratio, predomi- 
nantly  due to decreased  numbers of circulating  T lym- 
phocytes with the CD4 phenotype (8). Besides the de- 
crease  in  the  number of CD4+ lymphocytes, an intrinsic 
functional defect in the surviving  T cell population is also 
responsible for the variety of immunologic abnormalities 
that have been described in  this syndrome (9, 10). The 
most prominent abnormalities are a decreased blast 
transformation  in  response  to mitogens and  antigens, a 
decreased lymphokine production,  a  diminished  expres- 
sion of interleukin 2 receptors,  a  decreased alloreactivity, 
an impaired T cell clonability, the inability to provide 
help to B lymphocytes, a defective B lymphocyte function, 
and a defective monocyte function  (9-21). 
Since the introduction of serologic assays for the dem- 
onstration of antibodies  to HIV, it has become apparent 
that  the immunologic abnormalities, regularly observed 
in healthy male homosexuals during  recent  years, could 
be attributed to infection with HIV (22-24). However, 
little is known about  the  nature of the malfunction of the 
immune  system  in these asymptomatic HIV-seropositive 
individuals. In the present study we have investigated 
antigen-specific  antibody production in vivo and in vitro 
of peripheral blood mononuclear cells (PBMC) isolated 
from asymptomatic HIV-seropositive male homosexuals 
who had  recently been boosted with the  antigens  tetanus 
toxoid (TT) and the three types of poliovirus. In vitro 
antigen-specific  T and B cell functions were studied by 
stimulating PBMC with pokeweed mitogen (PWM) or with 
soluble (T  cell-dependent) and insolubilized (T cell-inde- 
pendent)  antigens.  Results of our  study  demonstrate that 
asymptomatic HIV-seropositive male homosexuals, as 
compared with  age-matched  heterosexual control individ- 
uals,  have  a  subnormal  increase in serum antibody titer 
after booster immunization,  a severely impaired in vitro 
antigen-specific T cell function and/or accessory cell 
function,  but an  antigen-specific B cell function which 
appears normal. 
MATERIALS AND METHODS 
Subjects. Five 25- to  35-yr-old  male  homosexuals  seropositive for 
HIV in several  enzyme-linked  immunosorbent  assay (ELISA) systems 
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including  Vironostika  (see below). who  had been diagnosed as clini- 
cally healthy.  volunteered  in this  study.  These  men  had been HIV- 
seropositive for a t  least  2 yr and so far exhibited a normal or slightly 
decreased CD4/CD8 ratio. Each HIV-seropositive male  homosexual 
had more than 0.7 X 10' CD4 cells/ml. The observed  decreased CD4/ 
CD8 ratios  were always  the  result of a n  increased CD8+ cell popula- 
tion. All  of the HIV-seropositive volunteers remained clinically 
healthy  during  this  study. Age-matched HIV-seronegative heterosex- 
ual male donors served as normal controls. Both HIV-seropositive 
and control donors  had been immunized with diphtheria,  tetanus 
toxoid, and polio vaccine during childhood and  they  had  not been 
reboosted during at least  the  last 2 yr. 
Immunfzatfon and  sarnplfng. All subjects, unless otherwise 
stated, received a n  intramuscular booster  immunization of one dose 
of diphtheria (D). tetanus (T), and polio vaccine  routinely produced 
in the National Institute of Public Health, The Netherlands. The 
vaccine  contained: 2.5 flocculation units (LF) D toxoid, 5 LF T toxoid 
(TT),  and killed poliovirus type 1 (Mahoney) 20 antigen  units (DU). 
type 2 (MEF) 2 (DU), and type 3 (Saukett) 3.5 (DU) per dose. Blood 
samples were collected before and 4 wk after immunization. PBMC 
were isolated from  heparinized blood  by density  gradient  centrifu- 
gation on Ficoll-lsopaque at 1000 x G for  20  min  and were then 
washed twice with RPMI 1640 (GIBCO, Grand Island. NY) supple- 
mented with penicillin (100 IU/ml) and streptomycin (100 pg/ml). 
PBMC were depleted of T  cells by two cycles of rosette  formation and 
separation  on Ficoll-Isopaque with 2-aminoethylisothiouronium bro- 
mide-treated sheep red blood cells as described elsewhere (25). Non- 
rosetting  cells  were treated  with RIV9. a CD3 monoclonal antibody 
of the IgG3 subclass (gift from Dr. J. G. Kreeftenberg. National 
Institute of Public Health and  Environmental Hygiene, Bilthoven, 
The Netherlands) plus complement (Cedarlane Lab., Inc., Hornby, 
Ontario, Canada)  and depleted of monocytes by differential  adher- 
ence  to plastic as described  elsewhere (26).  These  enriched B cell 
fractions contained less  than  0.1 % T  cells as determined by immu- 
nofluorescence microscopy using a fluoresceinated CD2 reagent 
(Leu-5: Becton Dickinson, Sunnyvale, CA). 
PBMC were  cultured at  2 X 10' cells/well and for PWM-induced B 
Culture condftfons. For antigen-induced B cell differentiation, 
cell differentiation, PBMC were  cultured at  10' cells/well. Cultures 
were performed in 24-wel1, flat-bottomed plates (Falcon 3074: Bec- 
ton Dickinson. Oxnard, CA) in RPMI 1640  containing penicillin (1 00 
IU/ml). streptomycin (100 pg/ml). L-glutamine (2 mM), and 2 x 
M j3-mercaptoethanol (complete RPMI). For insolubilized TT (see 
below) induced  B cell differentiation PBMC or purified  B  cells  were 
cultured at 4 x cells/well in 96-well round-bottomed microtiter 
plates (Greiner No. 650180)  in complete RPMI. Depending on the 
antigen  or mitogen used for  stimulation,  the  culture medium con- 
tained 10% fetal calf serum (Rehatuin Pharmaceutical Co.. Kan- 
kakee. IL) (poliovirus and PWM-stimulated cultures) or 10% pooled 
human AB serum (TT-stimulated cultures). After 10  days  stimula- 
tion with  different concentrations of poliovirus type  1,  2, or 3 (a gift 
from Dr. A. L. van Wezel. National Institute of Public Health and 
Environmental Hygiene, The Netherlands). culture supernatants 
were collected and tested in  the poliovirus neutralization  assay (see 
below). After 10  days of stimulation with PWM (80 pg/ml). culture 
supernatants were collected and  tested  in  ELSA (see below). After 
6 days of stimulation with different  concentrations of TT or insolu- 
bilized TT (ITT). cultured cells  were  washed twice with RPMI 1640 
and tested in the spot-ELISA (see below). For the antigen- and 
mitogen-induced proliferation, PBMC ( lo5 cells/well) were  cultured 
in round-bottomed  microtiter plates  with TT (1 LF/well) or PWM (80 
d m ] ) ,  respectively. All cultures were  performed in triplicate. After 
5 days of culture. cells were pulsed with 1 pCi [3Hjthymidine and 
after  18  hr  harvested  and counted in a scintillation counter. 
1 7 T .  Tetanus toxoid (a gift  from Dr. J. Nagel. National Institute of 
dialyzed against  0.1 M NaHC03 (pH 8.0) and adjusted to a concentra- 
Public Health and Environmental Hygiene, the Netherlands) was 
tion of 0.5 mg/ml. One milliliter of this solution was mixed with 1 
ml of sedimented. washed. n-hydroxysuccinimide ester of agarose 
(Affi-Gel 10 beads; Bio-Rad Laboratories,  Richmond, CA) and  incu- 
bated  for  4 hr   a t  room temperature while shaking continuously.  Free 
binding sites were blocked by the addition of 100 ml of 1 M ethanol- 
amine,  and  after  30 min the  beads were washed twice with  0.1 M 
NaHC03  (pH 8.0) and minimal essential medium (MEM)-Tris. Finally 
this iTT was resuspended  in MEM-Tris a t  a 1 : 1 ratio (v/v) and stored 
at  4°C. From this stock  solution,  all subsequent  dilutions were  made. 
Determfnatfon  ofpolfoulrus  type-speclffc  neutralizing  antfbody. 
The content of poliovirus type-specific neutralizing antibodies in 
culture  supernatant fluids or in  sera  was determined by a micro 
virus neutralization test as described in detail  elsewhere (27).  Titers 
of neutralizing  antibody were expressed as reciprocals of dilutions 
of supernatant  fluids neutralizing 100 TICD5O in  the  virus  neutral- 
ization test. 
ELISA. Anti-HIV-specific lgG was  assayed by ELISA (Vironostika 
anti-HIV-111 micro-elisa system, Organon Teknika BV. Boxtel. The 
Netherlands). TT-specific serum  titers were assayed by ELISA as 
described in detail  elsewhere  (28).  Total IgG in supernatant  fluids 
was assayed as previously described  (29). 
Spot-ELISA. B  cells secreting I g G  or IgM class  antibodies  to TT 
were enumerated by a modification of the spot-ELISA test as de- 
scribed by Sedgwick and Holt (30). Flat-bottomed 96-well microtiter 
plates (Greiner No. 655180) were coated with 100 pllwell 0.02% 
glutaraldehyde in  phosphate  buffer (pH 5) by incubation at  4OC for 
were filled with 100 pl of TT (4 LF/ml) in  phosphate buffer, pH 5. 
18 hr. After washing  with  phosphate-buffered  saline (PBS). wells 
After 2 hr  incubation at  37OC. plates were washed with PBS and 
were incubated for 45 min at 37OC with PBS, 1% bovine serum 
albumin (BSA) (Boseral. Organon Teknika,  Turnhout, Belgium). to 
block remaining binding sites. PBMC stimulation  in vitro  with TT or 
iTT and  nonstimulated control PBMC were  washed and added to TT- 
coated wells  in 100 pl RPMI 1640. 1 % BSA. at  a cell density of 10' 
cultured cells/ml. After 18  hr of incubation in a vibration-free in- 
cubator  in a humidified atmosphere of 5% COz in air  at 37°C. wells 
were  washed with PBS, 0.05% Tween-20,  and incubated  for  2 hr  at 
to  alkaline  phosphatase (Tag0 Inc.. Burlingame. CA) in PBS. 1 % BSA, 
37°C with affinity-purified goal anti-human IgM or IgG conjugated 
0.05% Tween-20. After washing with PBS, 0.05% Tween-20, the 
substrate 5-bromo-4-chloro-3-indolylphosphate (5-BCIP) was added 
in gelling agarose. The substrate was a 2.3 mM 5-BCIP (Sigma 
Chemical Co.. St. Louis, MO) solution in 0.1 M 2-amino-2-methyl-l- 
propanol buffer (Sigma) containing 5 mM MgC12.6H~. 0.01% Triton 
X-405 (Sigma),  0.01% NaN3. and  0.6% 36°C gelling agarose  (Sigma). 
After incubation a t  37T, IgG anti-TT-secreting  cells  became visible 
as blue spots which were counted after 18 hr using a n  inverted 
microscope. 
RESULTS 
In vivo response  to  booster  immunization. To inves- 
tigate the  in vivo capacity  to respond upon recall anti- 
gens, five asymptomatic HIV-seropositive male homosex- 
uals were immunized with TT and the three types of 
poliovirus. Before and 4 wk after immunization, tetanus 
and poliovirus antibody serum  titers were determined  in 
an  ELISA and  in virus  neutralization assay, respectively. 
As shown in Table I, all five donors  had protective levels 
of tetanus antibodies (>0.01 IU/ml) before immunization 
(31). Four of the five donors  also  had protective levels of 
poliovirus type 1, 2, or 3 neutralizing  antibodies (22) (32). 
After immunization with T T ,  the increase of anti-TT 
TABLE I 
TT and  polfoufrus  type 1 ,  2. or 3 antlbody  serum  tfters before  and 4 
wk after  booster lmmunfzatlon with a dlphterla  toxotd.  tetanus 
toxoid.  and  polfoufrus  uacclne 
Pollovirus-Neutrallzing 
Donors Tetanus Antlbody  Tlter Ant'body Titer lIU/mll (2 1%) 
I 11 111 
10 Pre 
Post 
11" Pre 
Post 
111" Pre 
Post 
IV" Pre 
Post 
V' Pre 
Post 
I"-V"  Pre 
Post 
Age-matched  controls'  Pre 
Post 
0.45 
0.95 
0.95 
1.05 
1.40 
1.65 
1.05 
1.90 
4.95 
1.90 
1.15 f 0.48 
2.00 f 1.47 
27.53 f 18.54 
3.16 f 2.55' 
12 52  52 
5 9 62 
11 12 11 
8 10 8 
5 5 5  
7 8 12 
11 5 3 
12 11 10 
10 11 10 
9 11 8 
9 f 3  1 0 f 2  9 f 4  
7 f 4   7 f 4  5 f 3  
l l f 2  1 1 f 3 1 2 f 3  
7*2= 7 f 4  4 f 3  
~~~~ ~~ 
a Asymptornatlc  HIV-seropositive  male  homosexual. 
Pre- or post-booster vaccination. 
HIV-seronegative heterosexuals. 
d n = 9 .  
e n  = 8. 
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serum  titers proved significantly  less than  the increase 
observed in  age-matched  control  individuals (p < 0.01, F- 
test). The differences in increase of virus-neutralizing 
serum antibody titers  against poliovirus type 1 ,  2, or 3 
between the asymptomatic HIV-seropositive donors, on 
the one hand,  and, on the  other  hand,  the age-matched 
controls were less  evident  (Table I). However, one  sero- 
positive donor (I) had an anti-poliovirus type 3 serum  titer 
52 before and  after immunization. 
In  vitro mitogen-induced IgG secretion. PBMC of the 
five asymptomatic HIV-seropositive male homosexuals, 
isolated 4 wk after booster immunization and PBMC of 
five nonimmunized healthy male heterosexuals were 
stimulated  with PWM. After 10 days of culture,  super- 
natants from unstimulated and PWM-stimulated cul- 
tures were assayed  for  the presence of total IgG and IgG 
anti-HIV. Unstimulated PBMC  of the seropositive donors, 
but not of the heterosexual  control  individuals,  sponta- 
neously secreted IgG (Fig. 1A). Part of this spontaneously 
secreted IgG consisted of antibodies directed to HIV. as 
measured  in ELISA (Fig. 1B). In PWM-stimulated cultures 
of PBMC from four  out of five HIV-seropositive donors, 
total IgG secretion  had  decreased,  whereas PBMC from 
only one seropositive donor showed a slightly increased 
IgG secretion as compared with the elevated IgG produc- 
tion by PWM-stimulated PBMC from the control individ- 
uals (Fig. 1A). Moreover, in PWM-stimulated cultures of 
PBMC from all five HIV-seropositive donors, HIV-specific 
antibody production had  decreased (Fig. 1B). None of the 
control individuals produced HIV-specific antibodies 
after stimulation  with PWM (Fig. 1B). In addition polio- 
virus  neutralizing  antibodies and antibodies directed to 
TT were not detected in supernatants of unstimulated or 
PWM-stimulated cultures of  PBMC from HIV-seropositive 
donors. 
Antigen-induced T cell-dependent antibody  produc- 
tion  in  vitro. Four weeks after  the booster immunization 
with TT and  the  three types of poliovirus, PBMC of the 
five asymptomatic HIV-seropositive male homosexuals 
and of five HIV-seropositive male heterosexuals were 
assayed for their  capacity  to produce specific antibody  in 
vitro. To that extent PBMC were cultured  with  different 
concentrations of soluble TT,  or poliovirus type 1 ,  2, or 
3. PBMC from five HIV-seronegative control  individuals 
produced anti-TT IgG (no  anti-TT IgM, data not shown) 
and poliovirus type 1,2,  and 3 neutralizing  antibody upon 
stimulation  with the respective antigens (Figs. 2 and 3). 
This in vitro induced antibody response proved to be 
specific since, in cultures of PBMC, anti-poliovirus-pro- 
ducing cells were not detected after stimulation  with  TT; 
similarly after stimulation  with poliovirus no production 
of anti-TT  was observed (data not shown). After culturing 
of PBMC from the five HIV-seropositive donors with sol- 
uble TT, no TT-specific IgG or IgM (data not shown) 
production could be detected in a spot-ELISA (Fig. 2). 
After 10 days of culturing of PBMC from  the HIV-sero- 
positive donors with poliovirus type 1 ,  2, or 3, respec- 
tively, cells from four out of five donors failed to produce 
detectable levels of poliovirus-neutralizing antibody as 
measured in the  virus neutralization  assay. PBMC from 
the  other seropositive donor did produce neutralizing an- 
tibodies against poliovirus type 2 and 3, but not against 
type 1 when  stimulated  with the respective antigens (Fig. 
Mitogen- and antigen-induced lymphocyte  prolifera- 
tion. Given the impaired T cell-dependent antigen or 
mitogen-induced B cell activation, proliferative responses 
upon  stimulation  with soluble TT (sTT) or PWM  of  PBMC 
from three of the HIV-seropositive individuals were eval- 
uated. A s  shown in Table 11, proliferative responses upon 
stimulation  with PWM or TT were low compared with the 
responses of PBMC from HIV-seronegative controls, ex- 
cept for donor 111 who showed a  response upon stimula- 
tion with PWM. This donor also demonstrated an  in- 
crease in total IgG production after stimulation with 
PWM, as shown  in Figure 1. 
Antigen-induced T cell-independent antibody pro- 
duction  in  vitro. It has previously been shown that  the 
3). 
total IgG  IgG anti- HIV 
IgG  fig lml  OD 150 
I g C  anti-HIV production and  the  influence 
FLgure 1.  Spontaneous total I g C  and 
of PWM stimulation on  the total IgC and 
IgC anti-HIV production of PBMC from 
five booster-immunized asymptomatic 
HIV-seropositive male homosexuals and 
five nonimmunized HIV-seronegative het- 
erosexual control individuals. Cultures 
were set up as  described in Materials  and 
Methods. After 6 days of culture, culture 
supernatants were collected and  assayed 
for total IgC and IgC anti-HIV  production 
in ELISA. q I ) ,  A(I1). O(III), V(1V). and O(V) 
= asymptomatic HIV-seropositive male 
homosexuals: 0 = HIV-seronegative male 
heterosexual control individuals. 
donors H I V  H I V  H I V  H IV  
seropositive seronegatwe seropositive seronegative 
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:L n 5 20 0 0  
0.02 0.2 T T  I LFlml) 
Figure 2. Number  of IgG anti-TT-producing cells  after stimulation of 
PBMC from TT booster-immunized individuals with  two different doses 
of TT. PBMC were isolated 4 wk after booster immunization and cultured 
a s  described in Materials and Methods. After 6 days of culture, cells 
were washed and assayed for specific antibody production in a spot 
ELISA. q I ) .  A(I1). lJ(ll1). V[IV), and O(V) = asymptomatic HIV-seropositive 
male homosexuals; 0 = HIV-seronegative male heterosexual control in- 
dividuals. 
autoantigen thyroglobulin coupled to a solid phase  can 
be used to  induce  antigen-specific  secondary type B cell 
responses  in vitro, independently of T cells (26, 33). In 
analogy, we coupled TT to Affi-Gel 10 (iTT) to examine 
whether  secondary  anti-TT  responses  independently of 
T cells could be raised. To demonstrate  the capacity of B 
cells to respond upon stimulation  with iTT without the 
involvement of T cells and  adherent cells, B cells of TT 
booster-immunized control  individuals were purified as 
described in Materials and Methods. 
PBMC and purified B cells were stimulated  with  serial 
dilutions of iTT and sTT and after 6 days of culture 
assayed for IgG anti-TT  antibody-forming cells in a  spot 
ELISA. Representative data from one control  donor are 
shown  in  Table 111. Stimulation of purified B cells and 
unseparated PBMC with iTT resulted  in the production 
of IgG anti-TT. In contrast to PBMC, purified B cells did 
not respond upon stimulation  with  sTT.  These data show 
that iTT activates  human B cells independently of T cell 
help  to the production of TT-specific antibody. 
We used this method to analyze the T  cell-independent 
responsiveness of B cells to TT from the HIV-seropositive 
donors. PBMC were stimulated with serial dilutions of 
iTT and examined for production of TT-specific antibody 
in comparison with production by PBMC from the HIV- 
seropositive controls. As  shown in Figure 4, PBMC from 
both HIV-seropositive and HIV-seronegative men could 
be stimulated equally well to IgG TT-specific antibody 
production. No IgM TT-specific antibody-forming cells 
were detected (data not  shown). 
DISCUSSION 
Previous studies on the function of the immune  system 
in HIV-infected individuals  have mainly been focused on 
patients  with AIDS or ARC. These  studies  demonstrated 
a severely impaired antibody  response induced by anti- 
gen or mitogen, without  elucidating the underlying mech- 
anisms (14-18). In the  present  report we have studied 
both T  cell-dependent and T  cell-independent  activation 
of 5 cells from asymptomatic HIV-seropositive male ho- 
mosexuals. To this end in vivo and in vitro antigen- 
specific immune responses were measured in TT and 
poliovirus (type 1, 2, and 3) booster-immunized asymp- 
tomatic HIV-seropositive male homosexuals and com- 
pared with those of similarly booster-immunized HIV- 
seronegative  heterosexual male individuals. 
Four weeks after immunization, all five seropositive 
donors showed a relative low and normal increase in 
serum  antibody titers to TT and polioviruses respectively, 
suggesting B cell activation  in vivo. Despite this in vivo 
observed responsiveness,  T cell-dependent antigen-  and 
mitogen-induced B cell differentiation in vitro proved to 
body after stimulation of  PBMC from 
Figure 3. Poliovirus-neutralizing anti- 
poliovirus type 1, 2, and 3 booster-immu- 
nized individuals with different doses of 
poliovirus type 1, 2. or 3. PBMC were iso- 
lated 4 wk after booster immunization 
and cultured as described in Matertats 
and Methods. After 10 days of culture. 
supernatants were collected and  assayed 
for poliovirus type 1, 2, and 3 neutralizing 
antibodies in the poliovirus neutralization 
assay. O(1). A(II), O[lll). V(IV). and O[V] 
asymptomatic HIV-seropositive male ho- 
mosexuals  [A); 0 = HIV-seronegative male 
heterosexuals (B). 
A 0 2%  14.4 72 360 1800ng x 0 1.6 8 LO 2001000ng 
Y 
0 2.8 lL,L 72 360 1800ng 0 1.6 8 LO 200 1000ng 
- 
2L 120 600 3000 ng 
E type B 
0 L.8 2L 120 600 3000ng 
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TABLE 11 
Mitogen- and  antigen-induced  lymphocyte  prollferation of PBMCfrorn 
TT booster  immunized  HIV-seropositiue  and  HIV-negatiue 
individuals" 
Donors  Unstimuiated PWM TT 
I b  66 f 9' 
IIlb 
2.471 f 128 
363 f 7 
626 f 130 
Vb 
11,710 f 916 
272 f 174  3.883 f 94 
2,135 f 188 
4,820 f 372 
Controld 407 f 49  13.487 f 2,343  19.934 f 1,099 
Controld 712 f 338 12.080 f 1.913  19.537 f 2,924 
stimulated with TT ( 1 LF/well) or PWM (80 g/ml) .  After 5 days of culture 
a Four weeks  after booster immunization, PBMC ( 1 O5 cells/well) were 
proliferative responses were assayed as  described in Materials  and  Meth- 
OdS. 
Asymptomatic HIV-seropositive male homosexual. 
Values represent cpm and are expressed as  the  mean k SD of triplicate 
HIV-seronegative heterosexual. 
cultures. 
TABLE 111 
Number oflgC  anti-TT-producing  cells  after  stimulation f PBMC and 
serial  dilutions of insolubilized TT and  daerent  doses of soluble TT" 
purlfied B cellsfrom a booster-immunized control individual  with 
Numbers of ig Anti-TT Antibody- 
Forming  Cells/106 Cultured Cells Stimulus 
Purified B cells PBMC 
iTTb 
0 
1/100 
11200 
STT 
1 /400 
0 
0.2 ILF/mll 
0.02 (LFIml) 
0 
110 
30 
180 
0 
0 
0 
0 
145 
60 
140 
210 
0 
225 
Materials  and  Methods. 
scribed in Materials  and  Methods. 
" PBMC and purified B cells were cultured and assayed as  described in 
bDilutions of the Affi-Gel-bound TT stock solution prepared as  de- 
o 300 
m a 
I 
PBMC from TT booster-immunized individuals with different dilutions of 
Figure 4. Number of IgG anti-TT-producing cells  after stimulation of 
iTT. PBMC were isolated 4 wk after booster immunization and cultured 
as  described in Materials and Methods. The number of IgG anti-TT 
antibody-forming cells were assayed as  described in the legend of  Figure 
2. q l ) ,  A(11). O(III]. V(IV). and O(V] = asymptomatic HIV-seropositive male 
the Affi-Gel-bound TT stock solution prepared as described in Materials 
homosexuals: 0 = HIV-seronegative male heterosexuals. [* Dilutions of 
and  Methods.) 
be severely impaired in  these individuals. PBMC from the 
asymptomatic HIV-seropositive individuals  in  contrast o 
those of control  individuals failed to respond upon stim- 
ulation  with the soluble protein antigen TT or the  three 
types of poliovirus. For this impaired in vitro antigen- 
induced antibody synthesis,  the following explanations 
may be considered: the absence of functionally active 
antigen-specific memory B cells, an insufficient  T  helper 
cell activity, or an impaired accessory cell function. 
The  absence of functionally  active  antigen-specific B 
cells could be excluded, since  here we demonstrated that 
PBMC  of both HIV-seropositive and -seronegative individ- 
uals could  be triggered equally well to  anti-TT IgG pro- 
duction by iTT, which has shown to stimulate  human B 
cells, independently of T cell help and probably without 
the interference of adherent cells. The observed impaired 
antigen-induced  T  cell-dependent B cell responses,  but 
normal  T  cell-independent B cell responses suggest that 
T cell function  and/or accessory cell function rather  than 
B cell function is disturbed in these asymptomatic HIV- 
seropositive male homosexuals. Consistently, prolifera- 
tive responses of PBMC from the HIV-seropositive indi- 
viduals upon stimulation  with sTT proved relatively low 
when compared with  those from HIV-seronegative con- 
trol individuals. This  finding  confirms  recently published 
data showing low antigen-induced  responses of T cells 
from both patients with AIDS and asymptomatic HIV- 
seropositive individuals (9, 34). 
The possibility that accessory cells rather  than, or in 
addition to, T helper cells themselves, may have ac- 
counted for the observed impaired secondary immune 
responses  cannot be ruled out from the  data presented. 
Interestingly, it has been shown that both monocytes and 
macrophages are permissive for HIV infection and it is 
conceivable that a defective monocyte function as  de- 
scribed in AIDS patients may also play a role in the 
unresponsiveness of asymptomatic HIV-seropositive in- 
dividuals as reported here  (35-37). 
Patients  with AIDS or ARC often show hyperimmuno- 
globulinemia with  increased  numbers of circulating im- 
munoglobulin-secreting cells (14, 16, 17). Here we 
showed that  the PBMC  of asymptomatic HIV-seropositive 
male homosexuals  also  spontaneously produced elevated 
levels of IgG, including  antibodies directed toward HIV. 
Poliovirus-neutralizing antibodies  or  antibodies directed 
to TT were not detected in  the  culture  supernatants of 
these PBMC isolated 4 wk after  the booster immuniza- 
tion. Recently, Yarchoan et al. (18) demonstrated in a 
very sensitive  precursor  frequency  determination that in 
patients with AIDS or ARC part of the spontaneously 
produced antibodies comprised antibodies toward HIV 
and to at least one recall antigen and frequencies ob- 
served for recall antigen-specific B cells were lower than 
those for HIV-specific B cells. The  failure  to detect spon- 
taneously  secreted  antibodies directed to recall antigens 
may be inherent to  culture  conditions  and  sensitivity of 
the  assays used,  but is in agreement  with the observation 
that lymphoblastoid B cells,  spontaneously  secreting an- 
tibodies to an immunizing  agent,  independent of T cell 
help,  circulate only between 5 and 10 days  after immu- 
nization (38, 39). The detection of spontaneously pro- 
duced IgG directed to HIV may reflect recent or continu- 
ous  activation of HIV-specific B cells by the expression 
of HIV antigens in vivo. Furthermore, HIV has been 
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shown  to be a T cell-dependent polyclonal stimulator in 
vitro, which may also have accounted for the sponta- 
neous production of IgG, including  antibodies directed to 
HIV (18, 40, 41). In four  out of five seropositive donors, 
addition of PWM to the  cultures resulted  in a decreased 
spontaneous IgG production,  whereas HIV-specific anti- 
body production was  decreased  in  all five donors  tested. 
PWM-induced suppression of the  spontaneous Ig secre- 
tion of in vivo activated B cells, as  has been  demonstrated 
in several  systems, has been explained by the involve- 
ment of a  subset of PWM-inducible, in vivo preactivated 
CD8+ suppressor T cells (42,  43). This may represent a 
nonspecific physiologic control  system on activated B cell 
stages. More recently it was observed that in HIV-sero- 
positive asymptomatic  hemophiliacs,  abnormalities of in 
vitro PWM-induced Ig secretion coincided with HIV sero- 
positivity (24, 44). Thus,  an increased Ig production and 
in vitro anergy to mitogens such as PWM not only appears 
to be valid for  individuals  with AIDS or ARC but  seems  a 
general  phenomenon for individuals seropositive for HIV. 
Considering the  immune-stimulating  and  immune- 
suppressive  consequences of HIV infection, we conclude 
that  the impaired in vivo and  in vitro immune  functions 
of HIV-seropositive male homosexuals described in  this 
paper are  the  result of persistent HIV infection. 
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